Tag:

Stryker

Latest Headlines

Latest Headlines

Stryker gets FDA clearance to use Mako robot for hip replacement

Stryker announced FDA clearance to use the Mako robotic surgery system for total hip replacement, as well as the launch of a new bone matrix, and spine-stabilizing cervical plate at the American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas.

FDA will discuss challenges and opportunities of robotic surgery at public meeting this summer

The FDA is putting robot assisted surgery in the spotlight this summer. 

Med tech industry's expenditure on lobbying at an all-time high

The medical device tax is costing the med tech industry money--and so is lobbying to get rid of it.

S&N falls on Stryker buyback plan, buys into Latin American distributor

Smith & Nephew was down 8% on the March 3 news that Stryker now has a massive $2.6 billion authorization available for share repurchases. That's a significant shift in strategy for Stryker, which has been highly acquisitive in the last few years and has long been rumored as a potential buyer for Smith & Nephew.

Stryker may cool M&A fervor with $2.6B for share buybacks

Stryker is signaling that it could hit the brakes on acquisitions after an aggressive string of at least a half-dozen purchases over the past few years, including the $1.7 billion purchase of robotic surgery player Mako Surgical in December 2013.

Stryker digests a string of acquisitions--and it's a top priority to add more

An aggressive acquisition strategy in order to broaden its product usage in trauma units and hospitals continues to be the focus for Stryker.

At JP Morgan, Stryker CEO embraces sales reps, dismisses Smith & Nephew plan to eliminate them

Stryker CEO Kevin Lobo expounded on the importance of specialized sales forces during his presentation at the JP Morgan Healthcare Conference in San Francisco and took a jab at Smith & Nephew's contrasting rep-less pilot program, which aims to cut implant prices in half through the use of automation.

Rumors that Stryker will buy Smith & Nephew pick up steam

Bloomberg reports that Stryker is planning to offer a premium for the U.K.'s S&N of about 30%. Currently, the target has a valuation of about $16.3 billion. The sources say a tax inversion is not planned. However, one of the unnamed sources also says Stryker's management could change its mind.

Wall Street, media approve of Stryker's multi-year buying spree

In response to Zimmer's $13.4 billion bid for Biomet, rumor has it that Stryker will snatch up the other relatively small orthopedics player, the U.K.'s Smith & Nephew.

Covidien, Stryker tout stroke study that used their stents

A comparative study found that treatment of stroke using stent thrombectomy devices manufactured by Covidien and Stryker is twice as effective as treatment using medication alone.